|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
ES2293638T3
(es)
|
1994-03-25 |
2008-03-16 |
Isotechnika, Inc. |
Mejora de la eficacia de farmacos por deuteracion.
|
|
US6194410B1
(en)
|
1998-03-11 |
2001-02-27 |
Hoffman-La Roche Inc. |
Pyrazolopyrimidine and pyrazolines and process for preparation thereof
|
|
US6423751B1
(en)
|
1998-07-14 |
2002-07-23 |
The Brigham And Women's Hospital, Inc. |
Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
|
|
US6384032B1
(en)
|
1999-06-17 |
2002-05-07 |
Shionogi Bioresearch Corp. |
Inhibitors of IL-12 production
|
|
EP1185528A4
(en)
|
1999-06-17 |
2003-03-26 |
Shionogi Biores Corp |
INHIBITORS OF IL-12 PRODUCTION
|
|
KR100774855B1
(ko)
|
2000-04-27 |
2007-11-08 |
아스텔라스세이야쿠 가부시키가이샤 |
축합 헤테로아릴 유도체
|
|
US6680315B2
(en)
|
2000-06-15 |
2004-01-20 |
Synta Pharmaceuticals Corp. |
Triazine compounds
|
|
WO2002022605A1
(en)
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6989385B2
(en)
|
2000-12-21 |
2006-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
WO2002088079A2
(en)
|
2001-05-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Dual inhibitors of pde 7 and pde 4
|
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
|
CA2450934A1
(en)
|
2001-06-19 |
2002-12-27 |
Marco Dodier |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
|
AU2003255845A1
(en)
|
2002-08-22 |
2004-03-11 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
|
US8673924B2
(en)
|
2002-09-04 |
2014-03-18 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
|
US7550470B2
(en)
|
2002-12-11 |
2009-06-23 |
Merck & Co. Inc. |
Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors
|
|
US7557110B2
(en)
|
2003-02-28 |
2009-07-07 |
Teijin Pharma Limited |
Pyrazolo[1,5-A] pyrimidine derivatives
|
|
JP2004277337A
(ja)
|
2003-03-14 |
2004-10-07 |
Sumitomo Pharmaceut Co Ltd |
ピラゾロ［１，５−ａ］ピリミジン誘導体
|
|
US7700583B2
(en)
|
2003-04-11 |
2010-04-20 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
|
WO2005000404A2
(en)
|
2003-05-29 |
2005-01-06 |
Synta Pharmaceuticals, Corp. |
Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
|
|
TWI376370B
(en)
|
2003-07-23 |
2012-11-11 |
Synta Pharmaceuticals Corp |
Compounds for inflammation and immune-related uses
|
|
AR045582A1
(es)
|
2003-09-05 |
2005-11-02 |
Neurogen Corp |
Piridinas pirazinas y pirimidinas heteroarilo fusionadas como ligandos receptores de crf1
|
|
AU2004272437A1
(en)
|
2003-09-09 |
2005-03-24 |
Ono Pharmaceutical Co., Ltd. |
CRF antagonists and heterobicyclic compounds
|
|
AU2004289304A1
(en)
|
2003-11-10 |
2005-05-26 |
Synta Pharmaceuticals, Corp. |
Pyridine compounds
|
|
AU2004289303A1
(en)
|
2003-11-10 |
2005-05-26 |
Synta Pharmaceuticals, Corp. |
Fused heterocyclic compounds
|
|
WO2006007532A2
(en)
|
2004-07-01 |
2006-01-19 |
Synta Pharmaceuticals Corp. |
2-substituted heteroaryl compounds
|
|
DE502005008916D1
(de)
|
2004-07-23 |
2010-03-11 |
Medicines Co Leipzig Gmbh |
Substituierte pyridoä3',2':4,5üthienoä3,2-düpyrimidine und pyridoä3',2':4,5üfuroä3,2-dü-pyrimidine zur verwendung als inhibitoren der pda-4 und/oder tnf-alpha freisetzung
|
|
KR20070057965A
(ko)
|
2004-09-21 |
2007-06-07 |
신타 파마슈티칼스 코프. |
염증 및 면역 관련 용도를 위한 화합물
|
|
TW200628463A
(en)
|
2004-11-10 |
2006-08-16 |
Synta Pharmaceuticals Corp |
Heteroaryl compounds
|
|
AU2005306471B2
(en)
|
2004-11-19 |
2009-12-17 |
Synta Pharmaceuticals Corp. |
Bis(thio-hydrazide amides) for increasing Hsp70 expression
|
|
JP2006160628A
(ja)
|
2004-12-03 |
2006-06-22 |
Ishihara Sangyo Kaisha Ltd |
アデノシンＡ２ａ受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
|
|
KR20140018997A
(ko)
|
2005-01-07 |
2014-02-13 |
신타 파마슈티칼스 코프. |
염증 및 면역 관련 용도를 위한 화합물
|
|
EP1846388A4
(en)
|
2005-01-25 |
2011-12-07 |
Synta Pharmaceuticals Corp |
THIOPHEN COMPOUNDS FOR IGNITIONS AND THE IMMUNE SYSTEM APPLICATIONS
|
|
PL1848435T3
(pl)
|
2005-01-25 |
2016-08-31 |
Synta Pharmaceuticals Corp |
Związki przeciwko zapaleniom i zastosowania związane z odpornością
|
|
US7473694B2
(en)
|
2005-03-17 |
2009-01-06 |
Teijin Pharma Limited |
Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
|
WO2007023382A2
(en)
|
2005-08-25 |
2007-03-01 |
Pfizer Inc. |
Pyrimidine amino pyrazole compounds, potent kinase inhibitors
|
|
BRPI0614884A2
(pt)
|
2005-08-25 |
2011-04-19 |
Hoffmann La Roche |
inibidores de p38 map cinase e métodos para uso dos mesmos
|
|
AR057979A1
(es)
|
2005-10-06 |
2008-01-09 |
Schering Corp |
PIRAZOLPIRIMIDINAS COMO INHIBIDORAS DE PROTEíNA QUINASA. COMPOSICIONES FARMACEUTICAS.
|
|
TW200804307A
(en)
|
2005-10-27 |
2008-01-16 |
Synta Pharmaceuticals Corp |
Process for preparing mesylate salts of IL-12 inhibitory compounds
|
|
JP5161102B2
(ja)
|
2005-11-22 |
2013-03-13 |
クドス ファーマシューティカルズ リミテッド |
ｍＴＯＲ阻害剤としてのピリドピリミジン、ピラゾピリミジンおよびピリミドピリミジン誘導体
|
|
WO2007071688A1
(en)
|
2005-12-22 |
2007-06-28 |
L'oréal |
Composition for dyeing keratin fibres with a tetraazapentamethine cationic direct dye, a particular oxidation base and a coupler
|
|
TW200806641A
(en)
|
2006-01-25 |
2008-02-01 |
Synta Pharmaceuticals Corp |
Substituted aromatic compounds for inflammation and immune-related uses
|
|
US7816535B2
(en)
|
2006-01-25 |
2010-10-19 |
Synta Pharmaceuticals Corp. |
Vinyl-phenyl derivatives for inflammation and immune-related uses
|
|
WO2007087429A2
(en)
|
2006-01-25 |
2007-08-02 |
Synta Pharmaceuticals Corp. |
Phenyl and pyridyl compounds for inflammation and immune-related uses
|
|
TW200806290A
(en)
|
2006-01-25 |
2008-02-01 |
Synta Pharmaceuticals Corp |
Substituted biaryl compounds for inflammation and immune-related uses
|
|
US8455658B2
(en)
|
2006-01-25 |
2013-06-04 |
Synta Pharmaceuticals Corp. |
Thiazole and thiadiazole compounds for inflammation and immune-related uses
|
|
US20070254926A1
(en)
|
2006-01-31 |
2007-11-01 |
Jun Jiang |
Pyridylphenyl compounds for inflammation and immune-related uses
|
|
EP1829879A1
(en)
|
2006-02-10 |
2007-09-05 |
Cellzome (UK) Ltd. |
Amino pyrimidine compounds for the treatment of inflammatory disorders
|
|
AU2007227210A1
(en)
|
2006-03-20 |
2007-09-27 |
Synta Pharmaceuticals Corp. |
Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
|
|
AU2007230911A1
(en)
|
2006-03-23 |
2007-10-04 |
Synta Pharmaceuticals Corp. |
Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
|
|
EP2003131A4
(en)
|
2006-04-04 |
2009-12-16 |
Taisho Pharmaceutical Co Ltd |
AMINOPYRROLIDINE COMPOUND
|
|
TW200801012A
(en)
|
2006-04-26 |
2008-01-01 |
Piramed Ltd |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
|
KR20090028819A
(ko)
|
2006-07-11 |
2009-03-19 |
얀센 파마슈티카 엔.브이. |
히스타민 ｈ４ 수용체의 벤조푸로- 및 벤조티에노피리미딘 조절제
|
|
RU2475478C2
(ru)
|
2006-08-21 |
2013-02-20 |
Синта Фармасьютиклз Корп. |
Соединения для лечения пролиферативных расстройств
|
|
US8785451B2
(en)
|
2006-08-21 |
2014-07-22 |
Synta Pharmaceuticals Corp. |
Compounds for the treatment of proliferative disorders
|
|
US8497272B2
(en)
|
2006-08-21 |
2013-07-30 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
US8779154B2
(en)
|
2006-09-26 |
2014-07-15 |
Qinglin Che |
Fused ring compounds for inflammation and immune-related uses
|
|
WO2008057246A2
(en)
|
2006-10-26 |
2008-05-15 |
Synta Pharmaceuticals Corp. |
Method for treating inflammatory disorders
|
|
US20080207641A1
(en)
|
2006-11-13 |
2008-08-28 |
Synta Pharmaceuticals Corp. |
Cyclohexenyl-aryl compounds for inflammation and immune-related uses
|
|
JP2010519206A
(ja)
|
2007-02-16 |
2010-06-03 |
シンタ ファーマシューティカルズ コーポレーション |
炎症及び免疫関連使用のための置換縮合環化合物
|
|
WO2008132502A1
(en)
|
2007-04-25 |
2008-11-06 |
Astrazeneca Ab |
Pyrazolyl-amino-substituted pyrimidines and their use for the treatment of cancer
|
|
US8093425B2
(en)
|
2007-04-30 |
2012-01-10 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
EP2164842A2
(en)
|
2007-05-24 |
2010-03-24 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
|
WO2009007753A2
(en)
|
2007-07-11 |
2009-01-15 |
Astrazeneca Ab |
4- (3-aminopyrazole) -pyrimidine derivativee and their use as tyrosine kinase inhibitors for the treatment of cancer
|
|
US8415340B2
(en)
|
2007-07-25 |
2013-04-09 |
Bristol-Myers Squibb Company |
Triazine kinase inhibitors
|
|
TW200906818A
(en)
|
2007-07-31 |
2009-02-16 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2695143A1
(en)
|
2007-08-01 |
2009-02-05 |
Synta Pharmaceuticals Corp. |
Heterocycle-aryl compounds for inflammation and immune-related uses
|
|
WO2009017831A1
(en)
|
2007-08-01 |
2009-02-05 |
Synta Pharmaceuticals Corp. |
Vinyl-aryl derivatives for inflammation and immune-related uses
|
|
CA2695148A1
(en)
|
2007-08-01 |
2009-02-05 |
Synta Pharmaceuticals Corp. |
Pyridine compounds for inflammation and immune-related uses
|
|
US8729111B2
(en)
|
2007-08-07 |
2014-05-20 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
CA2695989A1
(en)
|
2007-08-10 |
2009-02-19 |
Glaxosmithkline Llc |
Certain nitrogen containing bicyclic chemical entities for treating viral infections
|
|
US8324219B2
(en)
|
2007-09-20 |
2012-12-04 |
Synta Pharmaceuticals Corp. |
Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
|
|
CN101970440A
(zh)
|
2007-11-28 |
2011-02-09 |
先灵公司 |
作为蛋白激酶抑制剂的2-氟吡唑并[1，5-a]嘧啶类
|
|
US20110052643A1
(en)
|
2008-01-07 |
2011-03-03 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
WO2009100406A2
(en)
|
2008-02-07 |
2009-08-13 |
Synta Pharmaceuticals Corp. |
Topical formulations for the treatment of psoriasis
|
|
US8581004B2
(en)
|
2008-02-21 |
2013-11-12 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
AU2009300316A1
(en)
|
2008-10-01 |
2010-04-08 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
AU2009300317A1
(en)
|
2008-10-01 |
2010-04-08 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
AU2009300318A1
(en)
|
2008-10-01 |
2010-04-08 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
GB2465405A
(en)
|
2008-11-10 |
2010-05-19 |
Univ Basel |
Triazine, pyrimidine and pyridine analogues and their use in therapy
|
|
JP5578490B2
(ja)
*
|
2008-12-26 |
2014-08-27 |
味の素株式会社 |
ピラゾロピリミジン化合物
|
|
WO2010086040A1
(en)
|
2009-01-29 |
2010-08-05 |
Biomarin Iga, Ltd. |
Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
|
|
US20100204265A1
(en)
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
|
US8591943B2
(en)
|
2009-04-09 |
2013-11-26 |
Merck Sharp & Dohme Corp. |
Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors
|
|
SG179083A1
(en)
|
2009-09-11 |
2012-04-27 |
Cylene Pharmaceuticals Inc |
Pharmaceutically useful heterocycle-substituted lactams
|
|
WO2011081171A1
(ja)
|
2009-12-28 |
2011-07-07 |
味の素株式会社 |
スクリーニング方法
|
|
ES2540867T3
(es)
|
2010-02-26 |
2015-07-14 |
Mitsubishi Tanabe Pharma Corporation |
Compuestos de pirazolopirimidina y su uso como inhibidores de PDE10
|
|
WO2011146727A1
(en)
|
2010-05-19 |
2011-11-24 |
Philip Bosch |
Methods of treating interstitial cystitis
|
|
US20120083498A1
(en)
|
2010-06-17 |
2012-04-05 |
Fatah Kashanchi |
Modulators of Viral Transcription, and Methods and Compositions Therewith
|
|
PT3012258T
(pt)
|
2010-06-24 |
2018-12-14 |
Gilead Sciences Inc |
Composição farmacêutica compreendendo um derivado de pirazolo[1,5-a]pirimidina como agente antiviral
|
|
WO2012027240A1
(en)
|
2010-08-23 |
2012-03-01 |
Schering Corporation |
Fused tricyclic inhibitors of mammalian target of rapamycin
|
|
WO2012037116A2
(en)
|
2010-09-13 |
2012-03-22 |
The Children's Hospital Of Philadelphia |
Common and rare genetic variations associated with common variable immunodeficiency (cvid) and methods of use thereof for the treatment and diagnosis of the same
|
|
WO2012047569A1
(en)
|
2010-09-28 |
2012-04-12 |
Schering Corporation |
Fused tricyclic inhibitors of mammalian target of rapamycin
|
|
RU2013120966A
(ru)
|
2010-10-08 |
2014-11-20 |
Эббви Инк. |
ФУРО[3,2-d]ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ
|
|
EP2638032A1
(en)
|
2010-11-09 |
2013-09-18 |
Synta Pharmaceuticals Corp. |
Tetrazolyl - tetrahydropyridine compounds for inflammation and immune - related uses
|
|
US9234885B2
(en)
|
2011-01-25 |
2016-01-12 |
Albert Einstein College Of Medicine, Inc. |
Methods and assays for treating filoviridae infections
|
|
WO2012112245A1
(en)
|
2011-02-14 |
2012-08-23 |
Beth Israel Deaconess Medical Center, Inc. |
Modulation of phosphatidylinositol-5-phosphate-4-kinase activity
|
|
WO2012147890A1
(ja)
|
2011-04-27 |
2012-11-01 |
持田製薬株式会社 |
新規アゾール誘導体
|
|
WO2012170827A2
(en)
|
2011-06-08 |
2012-12-13 |
Cylene Pharmaceuticals, Inc. |
Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
|
|
JP5531066B2
(ja)
|
2011-08-24 |
2014-06-25 |
田辺三菱製薬株式会社 |
ピラゾロピリミジン化合物及びｐｄｅ１０阻害剤としてのその使用
|
|
WO2013028263A1
(en)
|
2011-08-24 |
2013-02-28 |
Glaxosmithkline Llc |
Pyrazolopyrimidine derivatives as pi3 kinase inhibitors
|
|
JP2014532656A
(ja)
|
2011-10-28 |
2014-12-08 |
シンタ ファーマシューティカルズ コーポレーション |
炎症および免疫関連用途のための化合物
|
|
AU2013249280B2
(en)
|
2012-04-17 |
2017-10-12 |
Gilead Sciences, Inc. |
Compounds and methods for antiviral treatment
|
|
CN103242341B
(zh)
|
2013-04-19 |
2015-12-09 |
中国科学院广州生物医药与健康研究院 |
噻吩并2，4取代嘧啶类化合物及其药物组合物与应用
|
|
EP2857004B1
(en)
|
2013-10-07 |
2018-07-04 |
The Procter and Gamble Company |
Hair straightening method involving reducing sugars
|
|
CN104557872B
(zh)
|
2013-10-16 |
2017-05-24 |
上海璎黎药业有限公司 |
稠合杂环化合物、其制备方法、药物组合物和用途
|
|
KR102320190B1
(ko)
|
2014-01-24 |
2021-11-03 |
에이아이 테라퓨틱스, 인코포레이티드 |
아필리모드 조성물 및 이를 사용하기 위한 방법
|
|
PL407081A1
(pl)
|
2014-02-05 |
2015-08-17 |
Celon Pharma Spółka Akcyjna |
Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK-2
|
|
KR20170002623A
(ko)
|
2014-05-14 |
2017-01-06 |
화이자 인코포레이티드 |
피라졸로피리딘 및 피라졸로피리미딘
|
|
EA035646B1
(ru)
|
2014-08-29 |
2020-07-21 |
Сиэйчдиай Фаундэйшн, Инк. |
Зонды для визуализации белка хантингтина
|
|
RU2739992C2
(ru)
|
2014-11-07 |
2020-12-30 |
ЭйАй ТЕРАПЬЮТИКС, ИНК. |
Композиции апилимода и способы их применения в лечении колоректального рака
|
|
CA2966359A1
(en)
|
2014-11-07 |
2016-05-12 |
Lam Therapeutics, Inc. |
Apilimod for use in the treatment of renal cancer
|
|
WO2016091774A1
(en)
|
2014-12-08 |
2016-06-16 |
Janssen Sciences Ireland Uc |
Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv)
|
|
WO2016112072A1
(en)
|
2015-01-07 |
2016-07-14 |
President And Fellows Of Harvard College |
Methods for treating or preventing ebolavirus or marburgvirus infections
|
|
WO2016118709A1
(en)
|
2015-01-23 |
2016-07-28 |
Lam Therapeutics, Inc. |
Anti-viral compositions containing pikfyve inhibitors and use thereof
|
|
WO2016126707A1
(en)
|
2015-02-03 |
2016-08-11 |
Lam Therapeutics, Inc. |
Apilimod compositions and methods for using same
|
|
CN105963300B
(zh)
|
2015-03-13 |
2019-06-11 |
中国人民解放军军事医学科学院放射与辐射医学研究所 |
PIKfyve抑制剂抗辐射损伤的用途
|
|
JP2018076234A
(ja)
|
2015-03-16 |
2018-05-17 |
大正製薬株式会社 |
ピラゾロ［１，５−ａ］ピリミジン化合物
|
|
US20180078561A1
(en)
|
2015-03-31 |
2018-03-22 |
Lam Therapeutics, Inc. |
Active metabolites of apilimod and uses thereof
|
|
WO2016161145A1
(en)
|
2015-03-31 |
2016-10-06 |
Dana-Farber Cancer Institute, Inc. |
Stk4 inhibitors for treatment of hematologic malignancies
|
|
PL236355B1
(pl)
|
2015-04-02 |
2021-01-11 |
Celon Pharma Spolka Akcyjna |
Pochodne 7-(morfolin-4-ylo)pirazolo[1,5-α]pirymidyny jako inhibitory kinazy PI3
|
|
US10758545B2
(en)
|
2015-06-25 |
2020-09-01 |
University Of Southern California |
Methods to treat neurological diseases
|
|
WO2017002120A1
(en)
|
2015-07-02 |
2017-01-05 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of senescent cells and uses thereof
|
|
TWI746449B
(zh)
|
2015-07-20 |
2021-11-21 |
美商Ａｉ治療公司 |
使用阿吡莫德治療癌症之方法
|
|
EP3324974B1
(en)
|
2015-07-24 |
2022-06-08 |
University Of Louisville Research Foundation, Inc. |
Compounds, compositions, methods for treating diseases, and methods for preparing compounds
|
|
GB201514754D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds
|
|
WO2017040971A1
(en)
|
2015-09-03 |
2017-03-09 |
Biomarin Pharmaceutical Inc. |
Methods of using inhibitors of pikfyve for the treatment of lysosomal storage disorders and neurodegenerative diseases
|
|
CA2999177A1
(en)
|
2015-09-24 |
2017-03-30 |
The Regents Of The University Of California |
Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment
|
|
GB201517263D0
(en)
|
2015-09-30 |
2015-11-11 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven |
Therapeutic agents
|
|
JP2018199623A
(ja)
|
2015-10-22 |
2018-12-20 |
大正製薬株式会社 |
含窒素縮合複素環化合物
|
|
EP3380476B1
(en)
|
2015-11-23 |
2020-09-30 |
Council of Scientific and Industrial Research |
Fused pyrimidines as isoform selective phosphoinositide-3-kinase-alpha inhibitors and process for preparation thereof
|
|
WO2017127661A1
(en)
|
2016-01-21 |
2017-07-27 |
Lam Therapeutics, Inc. |
Biomarkers for treating cancer with apilimod
|
|
CN105820175B
(zh)
|
2016-04-13 |
2019-09-20 |
四川大学 |
一种噻吩并嘧啶类化合物及其制备方法和应用
|
|
US20180036420A1
(en)
|
2016-08-03 |
2018-02-08 |
Lam Therapeutics, Inc. |
Methods for enhancing the delivery of molecules across the blood brain barrier
|
|
US20180050041A1
(en)
|
2016-08-19 |
2018-02-22 |
Lam Therapeutics, Inc. |
Compositions and Methods for Treating Niemann Pick C Disease
|
|
RU2019108279A
(ru)
|
2016-08-25 |
2020-09-25 |
ЭйАй ТЕРАПЬЮТИКС, ИНК. |
Композиции, содержащие ингибиторы pikfyve, и способы, связанные с ингибированием сигнального пути rank
|
|
GB201616237D0
(en)
|
2016-09-23 |
2016-11-09 |
Univ Oslo Hf |
Modulation of function of immune effector cells
|
|
BR112019007214A2
(pt)
|
2016-10-12 |
2019-07-02 |
Ai Therapeutics Inc |
composições do apilimode e métodos para uso do mesmo no tratamento do mal de alzheimer
|
|
JOP20190113A1
(ar)
|
2016-11-18 |
2019-05-15 |
Biocad Joint Stock Co |
مثبطات بروتون تيروزين كيناز
|
|
KR102654864B1
(ko)
|
2016-11-18 |
2024-04-05 |
삼성전자주식회사 |
유기금속 화합물, 이를 포함한 유기 발광 소자 및 이를 포함한 진단용 조성물
|
|
US20210062160A1
(en)
|
2017-01-09 |
2021-03-04 |
San Diego State University (SDSU) Foundation, dba San Diego State University Research Foundation |
Therapeutic and immunomodulatory bacteriophage formulations and methods for making and using them
|
|
US10021905B1
(en)
|
2017-01-17 |
2018-07-17 |
Modern Vital Inc. |
Smoking apparatus with a pump and a method of using same
|
|
US20190070166A1
(en)
|
2017-09-02 |
2019-03-07 |
Richard Postrel |
Optimized Method for Treating and Curing Arthritis, Diabetes, Multiple Sclerosis and Other Autoimmune Disease
|
|
WO2018138106A1
(en)
|
2017-01-27 |
2018-08-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of heart failure
|
|
CN106957303B
(zh)
|
2017-02-28 |
2019-06-04 |
中山大学 |
选择性Aurora A激酶抑制活性的喹唑啉衍生物及其制备方法以及应用
|
|
AU2018237598B2
(en)
*
|
2017-03-24 |
2023-12-14 |
Piksci Inc. |
Fused triazolo-pyrimidine compounds having useful pharmaceutical application
|
|
US10702534B2
(en)
|
2017-03-31 |
2020-07-07 |
AI Therapeutics, Inc. |
Compositions and methods relating to the radioprotective effects of apilimod
|
|
CN107163061A
(zh)
|
2017-04-14 |
2017-09-15 |
江西科技师范大学 |
含吡唑啉结构的噻吩并嘧啶类化合物的制备及应用
|
|
WO2018226150A1
(en)
|
2017-06-05 |
2018-12-13 |
Medivir Aktiebolag |
Pyrazolopyrimidine as malt-1 inhibitors
|
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
|
WO2019027765A1
(en)
|
2017-08-02 |
2019-02-07 |
Northwestern University |
SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS AND USES THEREOF
|
|
CN109384782A
(zh)
*
|
2017-08-04 |
2019-02-26 |
厦门大学 |
取代五元并六元杂环类化合物、其制备方法、药物组合及其用途
|
|
EP3676264A1
(en)
*
|
2017-08-28 |
2020-07-08 |
Acurastem Inc. |
Pikfyve kinase inhibitors
|
|
WO2019108665A1
(en)
|
2017-12-01 |
2019-06-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Autophagy modulators for use in treating cancer
|
|
WO2019113523A1
(en)
|
2017-12-08 |
2019-06-13 |
Ashok Bajji |
Compounds and therapeutic uses thereof
|
|
WO2019140380A1
(en)
|
2018-01-12 |
2019-07-18 |
Kymera Therapeutics, Inc. |
Protein degraders and uses thereof
|
|
TW202000205A
(zh)
|
2018-02-21 |
2020-01-01 |
美商Ａｉ治療公司 |
使用阿吡莫德與麩胺酸性劑的組合治療
|
|
WO2019210153A1
(en)
|
2018-04-27 |
2019-10-31 |
Novartis Ag |
Car t cell therapies with enhanced efficacy
|
|
CN108586486B
(zh)
|
2018-06-19 |
2021-03-02 |
四川大学 |
一种芳基取代噻吩并嘧啶类化合物的制备方法
|
|
EP3793544B1
(en)
|
2018-06-19 |
2023-09-20 |
Armaceutica, Inc |
Bifunctional compositions for the treatment of cancer
|
|
EP3817736A4
(en)
|
2018-07-05 |
2021-07-28 |
Mayo Foundation for Medical Education and Research |
PIKFYVE INHIBITORS
|
|
GB2576039B
(en)
|
2018-08-02 |
2021-01-06 |
Ip2Ipo Innovations Ltd |
A joint
|
|
CN110835345A
(zh)
|
2018-08-17 |
2020-02-25 |
中国科学院上海药物研究所 |
一类细胞周期依赖性激酶的降解剂、其制备方法、药物组合物及其用途
|
|
US20210033597A1
(en)
|
2018-12-31 |
2021-02-04 |
AcuraStem Incorporated |
Method for identifying effective treatments against neurodegenerative disorders
|
|
US20220144838A1
(en)
|
2019-03-13 |
2022-05-12 |
Nanjing Immunophage Biotech Co., Ltd. |
Compounds as Inhibitors of Macrophage Migration Inhibitory Factor
|
|
AU2020270981A1
(en)
|
2019-04-10 |
2021-11-04 |
Cornell University |
PIP4Ks suppress insulin signaling and enhance immune function through a catalytic-independent mechanism
|
|
CN112142744A
(zh)
|
2019-06-28 |
2020-12-29 |
上海瑛派药业有限公司 |
取代的稠合杂芳双环化合物作为激酶抑制剂及其应用
|
|
AR119934A1
(es)
|
2019-09-12 |
2022-01-19 |
Ai Therapeutics Inc |
Inhibidores de pikfyve para terapia contra el cáncer
|
|
JP7635228B2
(ja)
|
2019-11-08 |
2025-02-25 |
ベンティックス バイオサイエンシーズ，インク． |
Ｔｙｋ２偽キナーゼリガンド
|
|
US20220409617A1
(en)
|
2019-11-13 |
2022-12-29 |
The Regents Of The University Of California |
Drug Formulations and Methods of Treatment for Metabolic Disorders
|
|
TW202134245A
(zh)
|
2019-12-05 |
2021-09-16 |
美商邊際分析公司 |
稠合三環雜環化合物及其用途
|
|
TWI885039B
(zh)
|
2020-01-13 |
2025-06-01 |
美商邊際分析公司 |
經取代吡唑并嘧啶及其用途
|
|
NL2030835B1
(en)
|
2020-01-24 |
2022-12-29 |
Aim Immunotech Inc |
Methods, compositions, and vaccinces for treating a virus infection
|
|
WO2021155067A1
(en)
|
2020-01-28 |
2021-08-05 |
University Of Southern California |
Compositions and methods to treat neurological diseases
|
|
CA3170133A1
(en)
|
2020-02-07 |
2021-08-12 |
AI Therapeutics, Inc. |
Anti-viral compositions and methods of use
|
|
EP4103281A1
(en)
|
2020-02-11 |
2022-12-21 |
Acurastem Inc. |
Pikfyve kinase inhibitors
|
|
WO2021183439A1
(en)
|
2020-03-09 |
2021-09-16 |
Verge Analytics, Inc. |
Substituted furo[3,2-d]pyrimidines and uses thereof
|
|
US11806359B2
(en)
|
2020-03-31 |
2023-11-07 |
Phoenix Biotechnology, Inc. |
Method and compositions for treating Coronavirus infection
|
|
US20210338683A1
(en)
|
2020-05-01 |
2021-11-04 |
AcuraStem, Inc. |
Treatment of viral infections with combination of pikfyve kinase inhibitors and tmprss-2 inhibitors
|
|
EP4161523A4
(en)
|
2020-06-03 |
2024-07-03 |
Yumanity Therapeutics, Inc. |
BICYCLIC HETEROARENES AND METHODS OF USE THEREOF
|
|
US20240150358A1
(en)
|
2020-06-03 |
2024-05-09 |
Kineta, Inc. |
Purines and methods of their use
|
|
WO2021247859A1
(en)
|
2020-06-03 |
2021-12-09 |
Yumanity Therapeutics, Inc. |
Pyridopyrimidines and methods of their use
|
|
WO2021252895A2
(en)
|
2020-06-11 |
2021-12-16 |
Yumanity Therapeutics, Inc. |
Compositions and methods for the treatment and prevention of neurological disorders
|
|
IL299804A
(en)
|
2020-07-13 |
2023-03-01 |
Beijing Tide Pharmaceutical Co Ltd |
Pyrazolopyrimidine compounds for use as ATR kinase inhibitors
|
|
US20240018151A1
(en)
|
2020-10-19 |
2024-01-18 |
Tme Therapeutics Llc |
Novel inhibitors of pikfyve and methods using same
|
|
US20230364084A1
(en)
|
2020-10-28 |
2023-11-16 |
The Regents Of The University Of Michigan |
Methods for preventing or treating conditions related to pikfyve activity
|
|
WO2022094615A1
(en)
|
2020-10-29 |
2022-05-05 |
The Regents Of The University Of California |
Compounds and methods for increased antisense activity
|
|
WO2022235971A2
(en)
|
2021-05-06 |
2022-11-10 |
Systems Oncology, Llc |
Compositions for inhibiting growth of targeted cells
|
|
IL309143A
(en)
|
2021-06-11 |
2024-02-01 |
Orphai Therapeutics Inc |
Stabilized apilimod compositions and uses thereof
|
|
US12104159B2
(en)
|
2021-06-22 |
2024-10-01 |
AcuraStem Incorporated |
PIKFYVE antisense oligonucleotides
|